Structural perspectives on clinical β-lactamase inhibitors: From mechanism to resistance. [PDF]
Park SB, Kim MY, Cha SS.
europepmc +1 more source
<i>In vitro</i> activities of zosurabalpin and comparator antimicrobials against clinical isolates of carbapenem-resistant <i>Acinetobacter baumannii</i>. [PDF]
Lin Y-T +6 more
europepmc +1 more source
Emerging therapies and diagnostic innovations for multidrug-resistant infections in kidney allograft recipients: Challenges and future directions. [PDF]
Shetty A, Shankar M.
europepmc +1 more source
Novel Antibiotics and Emerging Resistance: <i>In Vitro</i> Activity of Five Antimicrobials Against Intensive Care Unit Isolates from a Turkish Tertiary Care Hospital. [PDF]
Kutlu HH +3 more
europepmc +1 more source
Drug-Drug Interactions in Recently Approved Antibacterials: A Mini Review. [PDF]
Baccari I, Bergmann F, Zeitlinger M.
europepmc +1 more source
Stewardship Challenges, PK/PD Evidence, and Prescribing Appropriateness for Recently Approved Antibiotics in Pediatric Practice. [PDF]
Romandini A +8 more
europepmc +1 more source
Update on the comparative <i>in vitro</i> activity of cefiderocol and four β-lactam-β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens. [PDF]
Wohlfarth E +8 more
europepmc +1 more source

